|View printer-friendly version|
In the U.S., at least half of all opioid overdose deaths involve a prescribed opioid medication, and nearly 80% of those deaths are considered accidental or unintentional. When opioids are taken at the same time as other prescription and non-prescription medications, they may be less effective for relieving pain. As a result, patients may take more frequent and higher doses, which can cause falls, hospitalizations, and even death. The challenges presented in opioid patients are exponentially amplified when patients, such as the elderly, have complex medication regimens.
Through proprietary, state-of-the-art technology, TRHC’s Optimized Opioid Solution can help curb opioid misuse (that can lead to abuse) before it starts – analyzing multi-drug risk to warn doctors about dangerous interactions and encourage safer prescribing choices.
“Competitive inhibition of drug metabolism can happen when two or more medications require the same enzyme in order to be activated or metabolized, and it is the root cause behind unintentional opioid misuse that may lead to abuse. As a result, patients taking opioids with other competing medications may not achieve the expected pain relief,” said
Conference attendees may visit the TRHC exhibit booth #109 to learn more about the Optimized Opioid Solution and the company’s mission of improving medication safety and optimizing patients’ pharmacotherapy outcomes.
TRHC works with major health plans, at-risk providers and PACE (Programs of All-Inclusive Care for the Elderly) throughout the country and was named by
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com.